Abstract
Summary
Targeted RNA-sequencing (RNA-Seq) is a highly accurate method for selecting and sequencing specific transcripts of interest and offers both quantitative and qualitative information. Targeted RNA-Seq can be achieved via either enrichment or amplicon-based approaches, both of which enable gene expression analysis in a focused set of genes of interest, with enrichment assays also providing the ability to detect both known and novel gene fusion partners in many sample types.
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
LPI (LP Information)' newest research report, the “Targeted RNA Sequencing Kits Industry Forecast” looks at past sales and reviews total world Targeted RNA Sequencing Kits sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted RNA Sequencing Kits sales for 2023 through 2029. With Targeted RNA Sequencing Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted RNA Sequencing Kits industry.
This Insight Report provides a comprehensive analysis of the global Targeted RNA Sequencing Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted RNA Sequencing Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Targeted RNA Sequencing Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted RNA Sequencing Kits and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted RNA Sequencing Kits.
The global Targeted RNA Sequencing Kits market size is projected to grow from US$ 1761.4 million in 2022 to US$ 2246.7 million in 2029; it is expected to grow at a CAGR of 2246.7 from 2023 to 2029.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted RNA Sequencing Kits market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Input Above 500ng RNA
100-500ng RNA
50-100ng RNA
Below 50ng RNA
Segmentation by application
For Eukaryotic (Animal, Plant, etc)
For Prokaryotic (Bacterial, etc)
For Human
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Illumina
Roche
Berry Genomics
Nucleus Biotech
Oxford Nanopore
Key Questions Addressed in this Report
What is the 10-year outlook for the global Targeted RNA Sequencing Kits market?
What factors are driving Targeted RNA Sequencing Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted RNA Sequencing Kits market opportunities vary by end market size?
How does Targeted RNA Sequencing Kits break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
In the report, we only collect information about the companies who can provide targeted RNA sequencing service.
LPI (LP Information)' newest research report, the “Targeted RNA Sequencing Kits Industry Forecast” looks at past sales and reviews total world Targeted RNA Sequencing Kits sales in 2022, providing a comprehensive analysis by region and market sector of projected Targeted RNA Sequencing Kits sales for 2023 through 2029. With Targeted RNA Sequencing Kits sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Targeted RNA Sequencing Kits industry.
This Insight Report provides a comprehensive analysis of the global Targeted RNA Sequencing Kits landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Targeted RNA Sequencing Kits portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Targeted RNA Sequencing Kits market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Targeted RNA Sequencing Kits and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Targeted RNA Sequencing Kits.
The global Targeted RNA Sequencing Kits market size is projected to grow from US$ 1761.4 million in 2022 to US$ 2246.7 million in 2029; it is expected to grow at a CAGR of 2246.7 from 2023 to 2029.
Market competition is not intense. Thermo Fisher, Illumina, Roche Holdings, BGI, Eurofins, etc. are the leaders of the industry, with about 52% market shares.
North America is the largest consumption place, with a consumption market share nearly 32%. Following North America, Europe is the second largest consumption place with the consumption market share of 28%.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted RNA Sequencing Kits market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Input Above 500ng RNA
100-500ng RNA
50-100ng RNA
Below 50ng RNA
Segmentation by application
For Eukaryotic (Animal, Plant, etc)
For Prokaryotic (Bacterial, etc)
For Human
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher
Illumina
Roche
Berry Genomics
Nucleus Biotech
Oxford Nanopore
Key Questions Addressed in this Report
What is the 10-year outlook for the global Targeted RNA Sequencing Kits market?
What factors are driving Targeted RNA Sequencing Kits market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Targeted RNA Sequencing Kits market opportunities vary by end market size?
How does Targeted RNA Sequencing Kits break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted RNA Sequencing Kits Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Targeted RNA Sequencing Kits by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Targeted RNA Sequencing Kits by Country/Region, 2018, 2022 & 2029
2.2 Targeted RNA Sequencing Kits Segment by Type
2.2.1 Input Above 500ng RNA
2.2.2 100-500ng RNA
2.2.3 50-100ng RNA
2.2.4 Below 50ng RNA
2.3 Targeted RNA Sequencing Kits Sales by Type
2.3.1 Global Targeted RNA Sequencing Kits Sales Market Share by Type (2018-2023)
2.3.2 Global Targeted RNA Sequencing Kits Revenue and Market Share by Type (2018-2023)
2.3.3 Global Targeted RNA Sequencing Kits Sale Price by Type (2018-2023)
2.4 Targeted RNA Sequencing Kits Segment by Application
2.4.1 For Eukaryotic (Animal, Plant, etc)
2.4.2 For Prokaryotic (Bacterial, etc)
2.4.3 For Human
2.5 Targeted RNA Sequencing Kits Sales by Application
2.5.1 Global Targeted RNA Sequencing Kits Sale Market Share by Application (2018-2023)
2.5.2 Global Targeted RNA Sequencing Kits Revenue and Market Share by Application (2018-2023)
2.5.3 Global Targeted RNA Sequencing Kits Sale Price by Application (2018-2023)
3 Global Targeted RNA Sequencing Kits by Company
3.1 Global Targeted RNA Sequencing Kits Breakdown Data by Company
3.1.1 Global Targeted RNA Sequencing Kits Annual Sales by Company (2018-2023)
3.1.2 Global Targeted RNA Sequencing Kits Sales Market Share by Company (2018-2023)
3.2 Global Targeted RNA Sequencing Kits Annual Revenue by Company (2018-2023)
3.2.1 Global Targeted RNA Sequencing Kits Revenue by Company (2018-2023)
3.2.2 Global Targeted RNA Sequencing Kits Revenue Market Share by Company (2018-2023)
3.3 Global Targeted RNA Sequencing Kits Sale Price by Company
3.4 Key Manufacturers Targeted RNA Sequencing Kits Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Targeted RNA Sequencing Kits Product Location Distribution
3.4.2 Players Targeted RNA Sequencing Kits Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Targeted RNA Sequencing Kits by Geographic Region
4.1 World Historic Targeted RNA Sequencing Kits Market Size by Geographic Region (2018-2023)
4.1.1 Global Targeted RNA Sequencing Kits Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Targeted RNA Sequencing Kits Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Targeted RNA Sequencing Kits Market Size by Country/Region (2018-2023)
4.2.1 Global Targeted RNA Sequencing Kits Annual Sales by Country/Region (2018-2023)
4.2.2 Global Targeted RNA Sequencing Kits Annual Revenue by Country/Region (2018-2023)
4.3 Americas Targeted RNA Sequencing Kits Sales Growth
4.4 APAC Targeted RNA Sequencing Kits Sales Growth
4.5 Europe Targeted RNA Sequencing Kits Sales Growth
4.6 Middle East & Africa Targeted RNA Sequencing Kits Sales Growth
5 Americas
5.1 Americas Targeted RNA Sequencing Kits Sales by Country
5.1.1 Americas Targeted RNA Sequencing Kits Sales by Country (2018-2023)
5.1.2 Americas Targeted RNA Sequencing Kits Revenue by Country (2018-2023)
5.2 Americas Targeted RNA Sequencing Kits Sales by Type
5.3 Americas Targeted RNA Sequencing Kits Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Targeted RNA Sequencing Kits Sales by Region
6.1.1 APAC Targeted RNA Sequencing Kits Sales by Region (2018-2023)
6.1.2 APAC Targeted RNA Sequencing Kits Revenue by Region (2018-2023)
6.2 APAC Targeted RNA Sequencing Kits Sales by Type
6.3 APAC Targeted RNA Sequencing Kits Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Targeted RNA Sequencing Kits by Country
7.1.1 Europe Targeted RNA Sequencing Kits Sales by Country (2018-2023)
7.1.2 Europe Targeted RNA Sequencing Kits Revenue by Country (2018-2023)
7.2 Europe Targeted RNA Sequencing Kits Sales by Type
7.3 Europe Targeted RNA Sequencing Kits Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Targeted RNA Sequencing Kits by Country
8.1.1 Middle East & Africa Targeted RNA Sequencing Kits Sales by Country (2018-2023)
8.1.2 Middle East & Africa Targeted RNA Sequencing Kits Revenue by Country (2018-2023)
8.2 Middle East & Africa Targeted RNA Sequencing Kits Sales by Type
8.3 Middle East & Africa Targeted RNA Sequencing Kits Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Targeted RNA Sequencing Kits
10.3 Manufacturing Process Analysis of Targeted RNA Sequencing Kits
10.4 Industry Chain Structure of Targeted RNA Sequencing Kits
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Targeted RNA Sequencing Kits Distributors
11.3 Targeted RNA Sequencing Kits Customer
12 World Forecast Review for Targeted RNA Sequencing Kits by Geographic Region
12.1 Global Targeted RNA Sequencing Kits Market Size Forecast by Region
12.1.1 Global Targeted RNA Sequencing Kits Forecast by Region (2024-2029)
12.1.2 Global Targeted RNA Sequencing Kits Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Targeted RNA Sequencing Kits Forecast by Type
12.7 Global Targeted RNA Sequencing Kits Forecast by Application
13 Key Players Analysis
13.1 Thermo Fisher
13.1.1 Thermo Fisher Company Information
13.1.2 Thermo Fisher Targeted RNA Sequencing Kits Product Portfolios and Specifications
13.1.3 Thermo Fisher Targeted RNA Sequencing Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Thermo Fisher Main Business Overview
13.1.5 Thermo Fisher Latest Developments
13.2 Illumina
13.2.1 Illumina Company Information
13.2.2 Illumina Targeted RNA Sequencing Kits Product Portfolios and Specifications
13.2.3 Illumina Targeted RNA Sequencing Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Illumina Main Business Overview
13.2.5 Illumina Latest Developments
13.3 Roche
13.3.1 Roche Company Information
13.3.2 Roche Targeted RNA Sequencing Kits Product Portfolios and Specifications
13.3.3 Roche Targeted RNA Sequencing Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Roche Main Business Overview
13.3.5 Roche Latest Developments
13.4 Berry Genomics
13.4.1 Berry Genomics Company Information
13.4.2 Berry Genomics Targeted RNA Sequencing Kits Product Portfolios and Specifications
13.4.3 Berry Genomics Targeted RNA Sequencing Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Berry Genomics Main Business Overview
13.4.5 Berry Genomics Latest Developments
13.5 Nucleus Biotech
13.5.1 Nucleus Biotech Company Information
13.5.2 Nucleus Biotech Targeted RNA Sequencing Kits Product Portfolios and Specifications
13.5.3 Nucleus Biotech Targeted RNA Sequencing Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Nucleus Biotech Main Business Overview
13.5.5 Nucleus Biotech Latest Developments
13.6 Oxford Nanopore
13.6.1 Oxford Nanopore Company Information
13.6.2 Oxford Nanopore Targeted RNA Sequencing Kits Product Portfolios and Specifications
13.6.3 Oxford Nanopore Targeted RNA Sequencing Kits Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Oxford Nanopore Main Business Overview
13.6.5 Oxford Nanopore Latest Developments
14 Research Findings and Conclusion